CareSuperb COVID-19 Antigen Test Usability

Completed · Not applicable

Conditions studied: COVID-19

In brief

The purpose of this study is to evaluate the usability of the CareSuperb COVID-19 Antigen Home Test in Home Use.

Key facts

Study ID

NCT05629455

Run by

AccessBio, Inc.

People needed

30

Starts

2022-11-17

Expected to finish

2022-11-22

Last updated by the study team

2023-02-06

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• An Institutional Review Board (IRB) approved informed consent / assent, if applicable, is signed and dated prior to any study-related activities.
• Male and female subjects 2 years of age and older.
• Subject is willing to provide a self-collected nasal swab sample. (If the subject is under the age of 14, an adult lay-user will collect the sample.)
• Subject agrees to complete all aspects of the study.

You may not qualify if…

• Subject has a visual impairment that cannot be restored with glasses or contact lenses.
• Subject has prior medical or laboratory training.
• Subject uses home diagnostics, e.g., glucose meters, HIV tests.
• Subject has prior knowledge of their current COVID-19 infection status.

Where it is running

• L&A Morales Healthcare Inc. — Miami, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.